City

Portland (1)

Overall Status

Active, not recruiting (1)

Sign in for free

Phase

phase 1 (1)

Sponsor

OHSU Knight Cancer Institute (1)

Collaborator

Novartis Pharmaceuticals (1)

Oregon Health and Science University (1)

Intervention

doxorubicin hydrochloride (1)

laboratory biomarker analysis (1)

pharmacological study (1)

ribociclib (1)

Study Documents

Intervention Type

drug (1)

other (1)

Funder Type

Other (1)

Study Type

Interventional (1)

undifferentiated (embryonal) sarcoma

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Advanced Soft Tissue Sarcoma, Locally Advanced Angiosarcoma, Locally Advanced Leiomyosarcoma Trial in Portland (Doxorubicin

Active, not recruiting

Advanced Soft Tissue Sarcoma
+26 more

Doxorubicin Hydrochloride
+3 more

Portland, Oregon

OHSU Knight Cancer Institute

Jan 6, 2023